Clinical benefits of thrombolytic therapy in acute myocardial infarction
- 3 January 1992
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 69 (2), A3-A11
- https://doi.org/10.1016/0002-9149(92)91167-3
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Thrombolysis and myocardial infarctionFibrinolysis, 1991
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- One-year outcome after therapy with tissue plasminogen activator: Report from the Thrombolysis and Angioplasty in Myocardial Infarction trialAmerican Heart Journal, 1990
- Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?Circulation, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trialThe American Journal of Cardiology, 1988
- Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.Circulation, 1988
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomographyThe American Journal of Medicine, 1982
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977